×
Diabetes

OXRA S 5/50 MG TAB


Rs 263 10 % Off


Package size

  • Rs 263
  • 15 Soft gelatin Capsules

    Estimate Delivery by: Tomorrow

    Delivering to 201301, Noida


    Easy 7 days return available

    Rs 263 10 % Off

    OXRA S 5/50 MG TAB

    Oxra S 5/50 Tablet 15's is a combination antidiabetic medication containing Dapagliflozin and Sitagliptin, used to manage type II diabetes mellitus in adults. Dapagliflozin works by inhibiting SGLT2 in the kidneys, promoting the excretion of glucose in the urine, thereby lowering blood glucose levels. Sitagliptin enhances the action of incretin hormones, increasing insulin synthesis and decreasing glucagon release, which helps control blood sugar levels. This dual-action mechanism makes Oxra S effective in patients inadequately controlled on metformin monotherapy. Common side effects include gastrointestinal disturbances, dizziness, and increased frequency of urination. Patients with severe kidney problems, those on dialysis, or with a history of pancreatitis should use this medication under strict medical supervision. Regular monitoring of blood glucose levels and adherence to a proper diet and exercise regimen are essential for optimal results.

    Product Highlights and Usage:

    Active Ingredients: Dapagliflozin 5 mg and Sitagliptin 50 mg. Uses: Manages type II diabetes mellitus in adults inadequately controlled on metformin monotherapy. Mechanism of Action: Dapagliflozin increases urinary glucose excretion, while Sitagliptin increases insulin synthesis and decreases glucagon release. Dosage Form: Oral tablets, taken with water as prescribed. Side Effects: Common side effects include nausea, headache, flatulence, constipation, dizziness, and increased urination.

    How it works:

    OXRA S 5/50 TABLET effectively manages blood sugar levels through a dual mechanism. Dapagliflozin inhibits SGLT2, leading to increased urinary glucose excretion and lower blood glucose levels. Simultaneously, sitagliptin inhibits DPP-4, which boosts the levels of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). This results in enhanced insulin production and reduced glucagon release.

    Directions for use:

    Take OXRA S 5/50 TABLET as directed by your physician. Swallow the tablet with a glass of water; do not crush or chew it. You can take OXRA S 5/50 TABLET with or without food. Your doctor will determine the appropriate dose and duration of therapy based on your age, body weight, and medical condition.

    Warning & Precaution:

    PREGNANCY MONITORING REQUIRED:OXRA S 5/50 TABLET may be used during pregnancy only if clearly necessary. Consult your doctor before taking it. BREASTFEEDING USE WITH CAUTION:OXRA S 5/50 TABLET can be used with caution in breastfeeding women. Consult your doctor before starting this medication. DRIVING AND USING MACHINES USE WITH CAUTION:Avoid driving or operating machinery if you feel dizzy or drowsy after taking OXRA S 5/50 TABLET. ALCOHOL CONSULT YOUR DOCTOR:Avoid alcohol while taking OXRA S 5/50 TABLET, as it may increase the risk of diabetic ketoacidosis. Consult your doctor for guidance. KIDNEY USE WITH CAUTION:OXRA S 5/50 TABLET should be used with caution in patients with a history of or current kidney problems. Consult your doctor before using this medication. LIVER USE WITH CAUTION:OXRA S 5/50 TABLET should be used with caution in patients with severe liver impairment. Consult your doctor before taking it. ALLERGY CONTRAINDICATED:Do not take OXRA S 5/50 TABLET if you are allergic to Dapagliflozin, Sitagliptin, or any other components of this medication. HEART DISEASE USE WITH CAUTION:OXRA S 5/50 TABLET should be used with caution in patients with a history of heart failure. Consult your doctor before starting this medication. USE IN PEDIATRICS CONSULT YOUR DOCTOR:The safety and effectiveness of OXRA S 5/50 TABLET in children and adolescents (under 18 years) have not been established. Consult your child’s doctor for advice. USE IN GERIATRICS CONSULT YOUR DOCTOR:No dose adjustment is needed for elderly patients, but consult your doctor before using OXRA S 5/50 TABLET.

    4.2
    Date

    Super Admin

    Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s

    medicare-logo-white

    APMEDCARE: Your digital partner in navigating secure, accessible healthcare services.

    Recent Posts

    Our services

    Copyright @ AXOLAB PHARMACEUTICALS PRIVATE LIMITED, 2025. All rights reserved.